Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

Biom’Up S.A. (Euronext: BUP)

Headquartered in France, Biom’Up designs hemostatic products based on patented biopolymers that aim to simplify surgical procedures in numerous specialties (spine, cardiothoracic, general, orthopedic, plastic). Its flagship product, HEMOBLAST™ Bellows, is a unique hemostatic solution, ready to use and is usable once or several times during the surgery. Developed by a world-renowned scientific team, HEMOBLAST™ Bellows has obtained positive results for all the primary and secondary endpoints of Phase III of its pivotal study involving 412 patients in the United States. A PMA (Pre-Market Approval) application for HEMOBLAST™ Bellows was submitted to the FDA (Food & Drug Administration) in July 2017 with a view to obtaining marketing approval in the United States in mid-2018. Since its creation, Biom’Up has benefited from the support of prominent European investors such as Bpifrance, Innobio, GIMV, Lundbeckfond, Mérieux Participation, SHAM and ACG. *

 

Period Start 0105-01-01 established
Products Industry biomaterials
  Industry 2 medical device
Persons Person Binant, Étienne (Biom’Up 201509 CEO)
  Person 2 Forest, Patricia (Biom’Up SA 201310 Deputy CEO + Scientific Director)
     
Region Region Lyon
  Country France
  Street 8 allée Irène Joliot Curie
Parc Technologique de Lyon
  City 69800 Saint-Priest
  Tel +33-4-8657-3610
    Address record changed: 2020-12-02
     
Basic data Employees B: 11 to 50 (2013-10-25)
  Currency EUR
  Annual sales 3,000,000 (turnover (2014) 2014-12-31)
     
    * Document for »About Section«: Bryan, Garnier & Co., Ltd.. (10/11/17). "Press Release: Bryan Garnier & Co Acts as Sole Global Coordinator for Biom'Up's Landmark Euronext IPO, Raising up to €44 Million including Greenshoe".
     
   
Record changed: 2024-02-12

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Biom’Up S.A. (Euronext: BUP)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top